Role of Radiation Treatment for Renal Cell Carcinoma

Radiation for renal cell carcinoma may be used

• for palliation of local symptoms or symptoms of metastatic disease

Radiotherapy should be considered in the context of a multi-disciplinary assessment by medical, surgical and radiation oncologists.

Indications

Palliative: Symptomatic local or metastatic disease, either as primary treatment or as an adjuvant to surgery. Stereotactic treatment can provide high dose radiotherapy to both intracranial and extracranial oligometastases, if a non-operative approach is being considered.

Benefits

• Palliative radiotherapy offers an effective alternative to surgery for symptom control in selected patients. 
• Adjuvant radiotherapy can reduce the risk or delay local recurrence of surgically treated metastatic disease. 
• Sterotactic dose escalated radiotherapy can provide long-term control of oligometastatic disease.

How to Obtain a Consultation

Patients may be referred to one of the radiation oncologists in the Site Group

• through the departmental referral process
• by contacting Elena Gessas
  • Tel: (416) 946-2121
  • Fax: (416) 946-4442
• by contacting one of the radiation oncologists directly

This page was last updated June 23rd, 2010 at 10:05am.